Terms: = Brain cancer AND BCL11A, BCL11A-L, 53335, ENSG00000119866, FLJ34997, CTIP1, BCL11A-S, BCL11A-XL, KIAA1809, Q9H165, EVI9, FLJ10173
8 results:
1. Network Analysis Identifies Regulators of Basal-Like Breast cancer Reprogramming and Endocrine Therapy Vulnerability.
Choi SR; Hwang CY; Lee J; Cho KH
Cancer Res; 2022 Jan; 82(2):320-333. PubMed ID: 34845001
[TBL] [Abstract] [Full Text] [Related]
2. The transcription factor bcl11a defines distinct subsets of midbrain dopaminergic neurons.
Tolve M; Ulusoy A; Patikas N; Islam KUS; Bodea GO; Öztürk E; Broske B; Mentani A; Wagener A; van Loo KMJ; Britsch S; Liu P; Khaled WT; Metzakopian E; Baader SL; Di Monte DA; Blaess S
Cell Rep; 2021 Sep; 36(11):109697. PubMed ID: 34525371
[TBL] [Abstract] [Full Text] [Related]
3. Tracking the Evolution of Non-Small-Cell Lung cancer.
Jamal-Hanjani M; Wilson GA; McGranahan N; Birkbak NJ; Watkins TBK; Veeriah S; Shafi S; Johnson DH; Mitter R; Rosenthal R; Salm M; Horswell S; Escudero M; Matthews N; Rowan A; Chambers T; Moore DA; Turajlic S; Xu H; Lee SM; Forster MD; Ahmad T; Hiley CT; Abbosh C; Falzon M; Borg E; Marafioti T; Lawrence D; Hayward M; Kolvekar S; Panagiotopoulos N; Janes SM; Thakrar R; Ahmed A; Blackhall F; Summers Y; Shah R; Joseph L; Quinn AM; Crosbie PA; Naidu B; Middleton G; Langman G; Trotter S; Nicolson M; Remmen H; Kerr K; Chetty M; Gomersall L; Fennell DA; Nakas A; Rathinam S; Anand G; Khan S; Russell P; Ezhil V; Ismail B; Irvin-Sellers M; Prakash V; Lester JF; Kornaszewska M; Attanoos R; Adams H; Davies H; Dentro S; Taniere P; O'Sullivan B; Lowe HL; Hartley JA; Iles N; Bell H; Ngai Y; Shaw JA; Herrero J; Szallasi Z; Schwarz RF; Stewart A; Quezada SA; Le Quesne J; Van Loo P; Dive C; Hackshaw A; Swanton C;
N Engl J Med; 2017 Jun; 376(22):2109-2121. PubMed ID: 28445112
[TBL] [Abstract] [Full Text] [Related]
4. Strict in vivo specificity of the
Smith EC; Luc S; Croney DM; Woodworth MB; Greig LC; Fujiwara Y; Nguyen M; Sher F; Macklis JD; Bauer DE; Orkin SH
Blood; 2016 Nov; 128(19):2338-2342. PubMed ID: 27707736
[TBL] [Abstract] [Full Text] [Related]
5. Identifying candidate genes for 2p15p16.1 microdeletion syndrome using clinical, genomic, and functional analysis.
Bagheri H; Badduke C; Qiao Y; Colnaghi R; Abramowicz I; Alcantara D; Dunham C; Wen J; Wildin RS; Nowaczyk MJ; Eichmeyer J; Lehman A; Maranda B; Martell S; Shan X; Lewis SM; O'Driscoll M; Gregory-Evans CY; Rajcan-Separovic E
JCI Insight; 2016 Mar; 1(3):e85461. PubMed ID: 27699255
[TBL] [Abstract] [Full Text] [Related]
6. bcl11a enhancer dissection by Cas9-mediated in situ saturating mutagenesis.
Canver MC; Smith EC; Sher F; Pinello L; Sanjana NE; Shalem O; Chen DD; Schupp PG; Vinjamur DS; Garcia SP; Luc S; Kurita R; Nakamura Y; Fujiwara Y; Maeda T; Yuan GC; Zhang F; Orkin SH; Bauer DE
Nature; 2015 Nov; 527(7577):192-7. PubMed ID: 26375006
[TBL] [Abstract] [Full Text] [Related]
7. bcl11a is a SUMOylated protein and recruits SUMO-conjugation enzymes in its nuclear body.
Kuwata T; Nakamura T
Genes Cells; 2008 Sep; 13(9):931-40. PubMed ID: 18681895
[TBL] [Abstract] [Full Text] [Related]
8. The BCL11 gene family: involvement of bcl11a in lymphoid malignancies.
Satterwhite E; Sonoki T; Willis TG; Harder L; Nowak R; Arriola EL; Liu H; Price HP; Gesk S; Steinemann D; Schlegelberger B; Oscier DG; Siebert R; Tucker PW; Dyer MJ
Blood; 2001 Dec; 98(12):3413-20. PubMed ID: 11719382
[TBL] [Abstract] [Full Text] [Related]
